nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP1A2—urine—polycystic ovary syndrome	0.0974	0.142	CbGeAlD
Pyrazinamide—CYP3A4—urine—polycystic ovary syndrome	0.0705	0.102	CbGeAlD
Pyrazinamide—XDH—endometrium—polycystic ovary syndrome	0.0661	0.0961	CbGeAlD
Pyrazinamide—XDH—vagina—polycystic ovary syndrome	0.0495	0.072	CbGeAlD
Pyrazinamide—AOX1—adrenal cortex—polycystic ovary syndrome	0.047	0.0684	CbGeAlD
Pyrazinamide—XDH—endocrine gland—polycystic ovary syndrome	0.0463	0.0674	CbGeAlD
Pyrazinamide—AOX1—endometrium—polycystic ovary syndrome	0.042	0.0611	CbGeAlD
Pyrazinamide—AOX1—uterus—polycystic ovary syndrome	0.0387	0.0563	CbGeAlD
Pyrazinamide—AOX1—pituitary gland—polycystic ovary syndrome	0.038	0.0553	CbGeAlD
Pyrazinamide—AOX1—adipose tissue—polycystic ovary syndrome	0.0378	0.055	CbGeAlD
Pyrazinamide—AOX1—adrenal gland—polycystic ovary syndrome	0.0339	0.0494	CbGeAlD
Pyrazinamide—AOX1—female gonad—polycystic ovary syndrome	0.0317	0.046	CbGeAlD
Pyrazinamide—AOX1—vagina—polycystic ovary syndrome	0.0315	0.0457	CbGeAlD
Pyrazinamide—AOX1—endocrine gland—polycystic ovary syndrome	0.0294	0.0428	CbGeAlD
Pyrazinamide—CYP1A2—endocrine gland—polycystic ovary syndrome	0.0161	0.0235	CbGeAlD
Pyrazinamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0117	0.017	CbGeAlD
Pyrazinamide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00289	0.00925	CbGpPWpGaD
Pyrazinamide—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00263	0.00842	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.0026	0.00834	CbGpPWpGaD
Pyrazinamide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00244	0.00781	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.00243	0.00777	CbGpPWpGaD
Pyrazinamide—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00242	0.00774	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00239	0.00766	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00233	0.00744	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NMNAT3—polycystic ovary syndrome	0.00232	0.00744	CbGpPWpGaD
Pyrazinamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00223	0.00714	CbGpPWpGaD
Pyrazinamide—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00203	0.0065	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00194	0.00623	CbGpPWpGaD
Pyrazinamide—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00187	0.00597	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00185	0.00592	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NMNAT3—polycystic ovary syndrome	0.00181	0.00579	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.0018	0.00575	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00179	0.00575	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00178	0.0057	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SUOX—polycystic ovary syndrome	0.00178	0.0057	CbGpPWpGaD
Pyrazinamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00172	0.00552	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00169	0.00542	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00167	0.00535	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00165	0.00529	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LPCAT2—polycystic ovary syndrome	0.00165	0.00529	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SUOX—polycystic ovary syndrome	0.00165	0.00529	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00159	0.00508	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00157	0.00504	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00155	0.00497	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00154	0.00493	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ISYNA1—polycystic ovary syndrome	0.00154	0.00492	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.00141	0.0045	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TEAD2—polycystic ovary syndrome	0.00141	0.0045	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00141	0.0045	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00137	0.00439	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKR1C2—polycystic ovary syndrome	0.00131	0.00419	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TEAD2—polycystic ovary syndrome	0.00131	0.00419	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00131	0.00418	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00129	0.00413	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.00128	0.00409	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00128	0.00409	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00125	0.00399	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.00124	0.00398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00124	0.00398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00124	0.00398	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00123	0.00394	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00122	0.00392	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00121	0.00389	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.0012	0.00384	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPL37A—polycystic ovary syndrome	0.0012	0.00383	CbGpPWpGaD
Pyrazinamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.0012	0.00383	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00119	0.00381	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00118	0.00377	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00116	0.00372	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.00114	0.00364	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HMMR—polycystic ovary syndrome	0.00113	0.00363	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SRD5A1—polycystic ovary syndrome	0.00112	0.00358	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PNPLA2—polycystic ovary syndrome	0.0011	0.00351	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—STAR—polycystic ovary syndrome	0.00107	0.00341	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00106	0.00339	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SRD5A1—polycystic ovary syndrome	0.00104	0.00332	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00101	0.00323	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.001	0.00321	CbGpPWpGaD
Pyrazinamide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000991	0.00317	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—STAR—polycystic ovary syndrome	0.000991	0.00317	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000985	0.00315	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000961	0.00308	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000958	0.00307	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HMMR—polycystic ovary syndrome	0.00095	0.00304	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000949	0.00304	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKR1C1—polycystic ovary syndrome	0.000934	0.00299	CbGpPWpGaD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000923	0.00295	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000906	0.0029	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HMMR—polycystic ovary syndrome	0.000883	0.00283	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000882	0.00282	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF18—polycystic ovary syndrome	0.000867	0.00278	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RBP4—polycystic ovary syndrome	0.000859	0.00275	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HSD3B1—polycystic ovary syndrome	0.000842	0.0027	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LHB—polycystic ovary syndrome	0.000826	0.00265	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000823	0.00264	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000814	0.00261	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000812	0.0026	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000808	0.00259	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—GAB1—polycystic ovary syndrome	0.000791	0.00253	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000782	0.0025	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000781	0.0025	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000779	0.0025	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000775	0.00248	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NAMPT—polycystic ovary syndrome	0.000771	0.00247	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LHB—polycystic ovary syndrome	0.000768	0.00246	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000765	0.00245	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HSD3B2—polycystic ovary syndrome	0.000751	0.0024	CbGpPWpGaD
Pyrazinamide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000748	0.0024	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000729	0.00233	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKR1C1—polycystic ovary syndrome	0.000727	0.00233	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SULT2A1—polycystic ovary syndrome	0.00072	0.0023	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000719	0.0023	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKR1C3—polycystic ovary syndrome	0.000719	0.0023	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TNRC6B—polycystic ovary syndrome	0.000708	0.00227	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—RRM2—polycystic ovary syndrome	0.000697	0.00223	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000681	0.00218	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000679	0.00217	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000678	0.00217	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—YAP1—polycystic ovary syndrome	0.000672	0.00215	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SULT2A1—polycystic ovary syndrome	0.000669	0.00214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000668	0.00214	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—RRM2—polycystic ovary syndrome	0.000648	0.00208	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NAMPT—polycystic ovary syndrome	0.000646	0.00207	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000638	0.00204	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000635	0.00203	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000628	0.00201	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000626	0.00201	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—YAP1—polycystic ovary syndrome	0.000625	0.002	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000617	0.00198	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000617	0.00198	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000607	0.00194	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TCF7L2—polycystic ovary syndrome	0.000606	0.00194	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000602	0.00193	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NAMPT—polycystic ovary syndrome	0.0006	0.00192	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SLC2A4—polycystic ovary syndrome	0.000596	0.00191	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000593	0.0019	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP11A1—polycystic ovary syndrome	0.000593	0.0019	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000582	0.00186	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000578	0.00185	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PRL—polycystic ovary syndrome	0.000568	0.00182	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000563	0.0018	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKR1C3—polycystic ovary syndrome	0.00056	0.00179	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000555	0.00178	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP17A1—polycystic ovary syndrome	0.000551	0.00176	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000536	0.00172	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000529	0.00169	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000524	0.00168	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000523	0.00167	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000517	0.00166	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000516	0.00165	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TH—polycystic ovary syndrome	0.000513	0.00164	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000499	0.0016	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00049	0.00157	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TH—polycystic ovary syndrome	0.000477	0.00153	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NCOR1—polycystic ovary syndrome	0.000476	0.00152	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000469	0.0015	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000468	0.0015	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000468	0.0015	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NRG1—polycystic ovary syndrome	0.000467	0.0015	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SLC2A4—polycystic ovary syndrome	0.000464	0.00149	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP19A1—polycystic ovary syndrome	0.000436	0.0014	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000432	0.00138	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000426	0.00137	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTHFR—polycystic ovary syndrome	0.000421	0.00135	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GNAS—polycystic ovary syndrome	0.000419	0.00134	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000414	0.00133	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000408	0.00131	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IRS2—polycystic ovary syndrome	0.0004	0.00128	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NCOR1—polycystic ovary syndrome	0.000399	0.00128	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000398	0.00127	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GNAS—polycystic ovary syndrome	0.000389	0.00125	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.00038	0.00122	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000378	0.00121	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NCOR1—polycystic ovary syndrome	0.000371	0.00119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000363	0.00116	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000355	0.00114	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTHFR—polycystic ovary syndrome	0.000352	0.00113	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP1A1—polycystic ovary syndrome	0.000351	0.00113	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IRS1—polycystic ovary syndrome	0.00035	0.00112	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000348	0.00111	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000348	0.00111	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000343	0.0011	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—INS—polycystic ovary syndrome	0.000335	0.00107	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000334	0.00107	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000329	0.00105	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—polycystic ovary syndrome	0.000328	0.00105	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT2—polycystic ovary syndrome	0.000324	0.00104	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000323	0.00104	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000322	0.00103	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000316	0.00101	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SERPINE1—polycystic ovary syndrome	0.000307	0.000984	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000295	0.000945	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000293	0.00094	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARG—polycystic ovary syndrome	0.000286	0.000915	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—POMC—polycystic ovary syndrome	0.000282	0.000903	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—INS—polycystic ovary syndrome	0.00028	0.000898	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00028	0.000896	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000275	0.00088	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000275	0.00088	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000268	0.000859	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000268	0.000859	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARG—polycystic ovary syndrome	0.000266	0.000851	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000264	0.000846	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—POMC—polycystic ovary syndrome	0.000262	0.000839	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—INS—polycystic ovary syndrome	0.000261	0.000834	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00026	0.000833	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00025	0.000799	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000249	0.000797	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.00023	0.000738	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000218	0.000699	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000212	0.000679	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000212	0.000679	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000208	0.000667	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000206	0.000659	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000186	0.000595	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000178	0.000569	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000177	0.000567	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000175	0.000561	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000169	0.00054	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000166	0.000532	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000162	0.000517	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000161	0.000515	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000158	0.000506	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000153	0.00049	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—polycystic ovary syndrome	0.000146	0.000468	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000143	0.000459	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000141	0.000451	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000137	0.000438	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000136	0.000436	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	0.000131	0.000421	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	0.000126	0.000404	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000125	0.000402	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000125	0.000399	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000125	0.000399	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000124	0.000396	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000122	0.00039	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000118	0.000378	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000118	0.000377	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000116	0.000371	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000109	0.000348	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000105	0.000337	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000101	0.000325	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TH—polycystic ovary syndrome	0.0001	0.000321	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	9.76e-05	0.000312	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.74e-05	0.000312	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	9.62e-05	0.000308	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	9.17e-05	0.000294	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.09e-05	0.000291	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	8.94e-05	0.000286	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	8.19e-05	0.000262	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	7.8e-05	0.00025	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.74e-05	0.000248	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.53e-05	0.000241	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	7.39e-05	0.000237	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.08e-05	0.000227	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	6.89e-05	0.000221	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.32e-05	0.000202	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.02e-05	0.000193	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.71e-05	0.000183	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	5.59e-05	0.000179	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	5.51e-05	0.000176	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—INS—polycystic ovary syndrome	5.48e-05	0.000176	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.32e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.31e-05	0.000138	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.25e-05	0.000136	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.23e-05	0.000135	CbGpPWpGaD
